Kensaku Kasuga

Obu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study.

Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study.

Journal: Brain, behavior, & immunity - health

Published: May 28, 2026

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis.

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis.

Journal: Molecular neurodegeneration

Published: April 07, 2026

Reductions in regional cerebral blood flow and dopamine transporter uptake in a patient with Gerstmann-Sträussler-Scheinker disease harboring the prion protein gene P105L mutation.

Reductions in regional cerebral blood flow and dopamine transporter uptake in a patient with Gerstmann-Sträussler-Scheinker disease harboring the prion protein gene P105L mutation.

Journal: Journal of the neurological sciences

Published: March 16, 2026

Diagnostic delay in early-onset Alzheimer's disease in Japan: a retrospective study.

Diagnostic delay in early-onset Alzheimer's disease in Japan: a retrospective study.

Journal: BMC neurology

Published: March 02, 2026

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Journal: Frontiers in molecular neuroscience

Published: February 23, 2026

Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform.

Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform.

Journal: Alzheimer's research & therapy

Published: November 14, 2025

CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids.

CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids.

Journal: iScience

Published: November 13, 2025

Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort.

Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort.

Journal: The journal of prevention of Alzheimer's disease

Published: November 11, 2025

The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice.

The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice.

Journal: Frontiers in dementia

Published: October 31, 2025

Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis

Current Status and Future Perspectives of Biomarkers in Alzheimer's Disease Diagnosis

Journal: No shinkei geka. Neurological surgery

Published: October 06, 2025

Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in Japan.

Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in Japan.

Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society

Published: September 23, 2025

Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer's Disease.

Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer's Disease.

Journal: Biomolecules

Published: August 29, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026